MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial.
Sign Up to like & getrecommendations! Published in 2021 at "Leukemia research"
DOI: 10.1016/j.leukres.2021.106516
Abstract: BACKGROUND Treatment-free survival (TFS) in chronic myeloid leukemia (CML) is a new goal. This prospective study aims to evaluate imatinib discontinuation's feasibility and safety in patients with deep molecular response MR4 (BCR-ABL1 < 0.01 %… read more here.
Keywords: discontinuation results; median time; relapse; discontinuation ... See more keywords
Adherence to Pediatric Sepsis Treatment Recommendations at Emergency Departments
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Emergency Care"
DOI: 10.1097/pec.0000000000002801
Abstract: Objective Sepsis is one of the most urgent health care issues worldwide. Guidelines for early identification and treatment are essential to decrease sepsis-related mortality. Our aim was to collect data on the epidemiology of pediatric… read more here.
Keywords: sepsis; emergency; adherence; treatment ... See more keywords
Protein-losing enteropathy recurrence after pediatric heart transplantation: Multicenter case series.
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric transplantation"
DOI: 10.1111/petr.14295
Abstract: BACKGROUND Protein-losing enteropathy (PLE) is a devastating complication of the Fontan circulation. Although orthotopic heart transplantation (HTx) typically results in resolution of PLE symptoms, isolated cases of PLE relapse have been described after HTx. METHODS… read more here.
Keywords: ple; protein losing; transplantation; htx ... See more keywords
Community-based multiple screening for metabolic syndrome by innovative theory: A longitudinal study.
Sign Up to like & getrecommendations! Published in 2022 at "Public health nursing"
DOI: 10.1111/phn.13033
Abstract: The purpose of this research is to elucidate whether metabolic syndrome affects the rate of adoption of a new multiple cancer screening programme, based on the Diffusion of Innovation theory. The time to attend the… read more here.
Keywords: theory; disease; metabolic syndrome; study ... See more keywords
P122 Treatment with rituximab to demand in rheumatoid arthritis. effectiveness analysis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-ewrr2018.137
Abstract: Introduction Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been shown to be effective in the treatment of rheumatoid arthritis (RA). At present we have different treatment regimens in terms of the time… read more here.
Keywords: treatment; median time; time; months months ... See more keywords
Diagnosis and management of secondary epipapillary retinoblastoma
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2016-309899
Abstract: Background Reports on retinoblastoma relapse at the optic nerve head (ONH) are anecdotal and include only treatments by external beam radiotherapy (EBRT) or enucleation. We aimed to describe such cases, termed secondary epipapillary retinoblastoma, diagnosed… read more here.
Keywords: secondary epipapillary; diagnosis; epipapillary retinoblastoma; hhsd oct ... See more keywords
Endocrinopathies Following Allogeneic Stem Cell Transplantation: 10 Years Follow-up in 402 Patients
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117293
Abstract: Introduction Allogeneic stem cell transplantation (allo-HCT) survivors are at a defined relevant risk of developing long-term complications: the prevalence of chronic health conditions approaches 75% among HCT survivors. The endocrine system is one of the… read more here.
Keywords: diagnosis; treatment; median time; time ... See more keywords
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood.2020006288
Abstract: The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is used to treat indolent B-cell malignancies and chronic graft-versus-host disease (cGVHD). The potential for ibrutinib to abrogate pulmonary inflammatory cytokines, lung injury, and death was demonstrated in… read more here.
Keywords: ibrutinib; median time; covid; inhibitor ibrutinib ... See more keywords
Patient delay in the diagnosis of tuberculosis in Ethiopia: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-020-05524-3
Abstract: Background Delay in the diagnosis of Tuberculosis (TB) remains a major challenge against achieving effective TB prevention and control. Though a number of studies with inconsistent findings were conducted in Ethiopia; unavailability of a nationwide… read more here.
Keywords: delay diagnosis; patient delay; diagnosis; median time ... See more keywords
Proceedings of the 13th International Newborn Brain Conference: Neuroprotection strategies in the neonate.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of neonatal-perinatal medicine"
DOI: 10.3233/npm-229003
Abstract: BACKGROUND: Hypoxic-ischemic (HI) brain injury is one of the most common neurological problems observed in infants. Hypothermia is the only approved therapy for neonatal HI encephalopathy. This therapy is only partially protective, cannot be used… read more here.
Keywords: brain; neonatal rats; therapeutic hypothermia; hypothermia ... See more keywords